Home|Journals|Articles by Year Follow on Twitter| Subscribe to List

Directory for Medical Articles
 

Open Access

Review Article

Biomed Res Ther. 2017; 4(3): 1210-1227


Molecular basis of glaucoma and its therapeutical analysis in Pakistan: an overview

Luqman Khan, Muhammad Ali, Muhammad Qasim, Farhat Jabeen, Basharat Hussain.

Abstract
The human eye is an organ of vision. It plays a prime role in life, gives us the sense of sight, and enables to understand about the world around us. Visualization and interpretation of colors, shapes and dimensions of numerous objects is made possible by eye. Inherited eye diseases comprise 1/3 of all reported human genetic disorders. This review will focus on Glaucoma which comprises a predictable visual illnesses concerning optic nerve deterioration and if remains without any cure can result in failure in eyesight. The optical nerve injure comprises deterioration of the retinal ganglion cells (RGCs). Glaucoma represents a heterogeneous group of optic neuropathies with a complex genetic basis. These neuropathies gradually reduce vision without warning and often without symptoms. Different forms of glaucoma share some common clinical manifestations that usually include specific abnormal appearance of the optic nerve head, characteristic loss of visual field and chronic painless progression. Glaucoma is a progressive optical neuropathy considered by optical disc changes, nerve fiber film break, and visual field defects. Present-day treatment preferences predominantly targeting at reducing IOP by making use of pharmaceutical means, laser treatment and surgical procedure. Developed conducts target neuroprotection with vaccines, the hang-up of NO synthesis and apoptosis. Attaining a better appreciative of the pathogenesis can support in the improvement of novel handling options and, perhaps, even a remedy for glaucoma. There are more than 1.8million glaucoma patients in Pakistan and almost half of them have already lost their eyesight, permanently, due to delay in diagnosis and treatment. About 90% population in the country has no awareness about this disease, resultantly; more and more people are becoming permanently blind in Pakistan due to untreated glaucoma.

Key words: Eye, glaucoma, diagnosis, treatment, Pakistan


Full-text options

Full-text Article


Share this Article


Readers of this article also read the following articles
»In Vitro Comparison of Cytotoxicity of Four Root Canal Sealers on Human Gingival Fibroblasts
»Nonpharmaceutical Interventions for Military Populations During Pandemic Influenza
»Which should be treated first; coronary artery disease or celiac artery compression syndrome?
»The effect of atopy on asthma severity and asthma control in children with asthma
»Chitinolytic efficacy and secretion of cell wall degrading enzymes from Trichoderma spp. in response to phyto-pathological fungi
»Phytoremediation potential of Eichhornia crassipes for the treatment of
cadmium in relation with biochemical and water parameters
»Development of field technique for mass screening of chickpea
(Cicer arietinum L.) germ plasm under drought prone
environments
»A study to assess the effectiveness of video teaching programme on immunization regarding knowledge among the mothers of under five children admitted in paediatric wards of RMMCH at Chidambaram
»Recent Advances in Diagnostic Procedure for Endocrine Disorders in Dogs and Cats
»Journal author index



Advertisement
Applied Medical Research

SUBMIT YOUR ARTICLE NOW




ScopeMed.com
BiblioMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.